black box warning glp 1 glp-1 Semaglutide & weight loss – Zoë Harcombe Exploring the Side Effects of

[DOI] [PubMed] [Google Scholar] [146].Goadsby PJ, Edvinsson L (1993)

You should not take a GLP-1 drug if you have severe gastrointestinal conditions like inflammatory bowel disease (IBD) or gastroparesis or a personal or family history of multiple endocrine neoplasia 2A, multiple endocrine neoplasia 2B, medullary thyroid cancer, or pancreatitis

The "DIY" Way: If you don't have an official container, use a heavy-duty plastic household container with a tight-fitting, puncture-resistant lid

PlexusDx recommends baseline TSH measurement before starting semaglutide, then follow-up testing at 6 weeks, 12 weeks, and every 6 months thereafter if you have a history of thyroid disease